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S U M M A R Y
Background: Brucellosis, a disease endemic in many countries including Turkey, is a systemic infectious
disease. Cardiovascular complications are not frequent, and endocarditis is the main cardiac
manifestation of brucellosis. Pericarditis in the absence of concomitant endocarditis is extremely rare.
Methods: In this report, we present four patients with pericarditis caused by brucellosis in the absence of
concomitant endocarditis, along with a review of the published literature on brucellar pericarditis. We
also searched for clinically silent pericardial effusion among patients with brucellosis. We performed
routine transthoracic echocardiography (TTE) on 72 consecutive patients with newly diagnosed
brucellosis in the absence of any signs and symptoms of pericarditis over a period of 6 months.
Results: Three of our patients with brucellar pericarditis recovered fully after antibiotics. The other
patient received 6 days of antibiotic treatment, and her signs and symptoms regressed, but after this the
patient was lost to follow-up. We did not detect pericarditis among the 72 newly diagnosed patients.
Conclusions: Brucellar pericarditis is a rare clinical entity, and the morbidity and mortality in patients
with brucellar pericarditis is low. Pericardiocentesis should only be performed in patients with cardiac
tamponade. Moreover, the choice of antibiotics and the duration of treatment do not differ between
brucellosis cases with or without isolated pericarditis. Although the prevalence of pericarditis in
brucellosis is low, brucellar pericarditis should always be kept in mind in patients with acute or chronic
pericarditis, especially in areas where brucellosis is endemic.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Brucellosis is a worldwide zoonotic disease, which is particu-
larly endemic in the Mediterranean region, the Middle East, the
Arabian Peninsula, Central and South America, Asia, and Africa.1
According to data from the Turkish Ministry of Health in 2004, the
disease is most common in the southeastern region of Turkey.2
Humans are infected by close contact with an animal, or by the
consumption of meat or dairy products infected by bacteria of the
genus Brucella.3
Brucellosis is a systemic infection; skeletal muscle, spleen, liver,
and bone marrow, rich in reticuloendothelial cells, are the most
frequently involved sites. With its various clinical symptoms and
signs, it is sometimes difﬁcult to diagnose.4 However, the incidence
of cardiovascular complications in brucellosis, such as endocardi-
tis, myocarditis, or pericarditis, is reported to be as low as 1% of all
cases, with even fewer cases of myocarditis or pericarditis in the
absence of concomitant endocarditis being reported. Indeed,
myocarditis, pericarditis, and asymptomatic pericardial effusion* Corresponding author. Tel.: +90 505 539 53 80; fax: +90 412 258 00 50.
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presence of endocarditis.5
We present the cases of four patients with brucellar pericarditis
in the absence of concomitant endocarditis, and discuss these cases
along with a review of the published literature on brucellar
pericarditis.
2. Case reports
2.1. Case 1
A 79-year-old female patient was admitted to hospital due to 10
days of fever, dyspnea, fatigue, and generalized arthralgia. She also
referred to weight loss and night sweats. Her medical history was
unremarkable. She was living in a rural area and had a history of
eating fresh cheese. On physical examination, only tachypnea,
cardiac murmur, and hepatosplenomegaly were detected. Labora-
tory investigations revealed anemia, leukopenia, and thrombocy-
topenia, and an elevated C-reactive protein (CRP) level (Table 1).
Brucellosis was suspected, and a Brucella standard tube aggluti-
nation (STA) test was positive at a dilution of 1:320. Electrocardi-
ography (ECG) was normal, but chest radiography revealed
cardiomegaly. Transthoracic echocardiography (TTE) showedses. Published by Elsevier Ltd. All rights reserved.
Table 1
Laboratory ﬁndings on admission of four patients with brucellar pericarditis
Parameter (normal range) Case 1 Case 2 Case 3 Case 4
White blood cell count,  109/l (4.1–11.2) 3.7 6.4 13.8 4.6
Lymphocytosis, % (10–50) 62 67 76 65
Hemoglobin, g/dl (F: 12–16, M: 14–18) 10.6 10.2 9.7 8.6
Platelets,  109/l (150–400) 139 221 340 157
ESR, mm/h (0–15) 10 15 117 60
CRP, mg/dl (0–5) 8 8.72 149 93.3
ALT, IU/l (0–41) 32 27 40 36
AST, IU/l (0–40) 35 32 38 29
Urea, mg/dl (10–50) 41 36 61 39
Creatinine, mg/dl (0.5–0.9) 0.8 0.6 1.6 0.7
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; F, female; M, male.
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with an ejection fraction of 60%, pulmonary hypertension, and
marked pericardial effusion (7 mm of thickness) without signs of
cardiac tamponade. A blood culture remained sterile. She was
treated with oral doxycycline 100 mg twice daily plus oral
rifampin 600 mg once daily for 2 months. Her symptoms regressed
rapidly 7 days after the initiation of treatment, and no adverse drug
reactions were observed during the follow-up. Echocardiographic
studies at 3 weeks, 2 and 6 months after the start of treatment
showed no pericardial effusion. After a follow-up duration of 9
months, our patient was well with no signs of relapse.
2.2. Case 2
A 33-year-old male patient was admitted to hospital with fever,
weight loss, dyspnea, palpitations, fatigue, and generalized
arthralgia of 15-day duration. He was working as a food handler.
On physical examination, he had tachycardia and hepatospleno-
megaly. Laboratory investigations revealed anemia, an elevated
CRP level, and high erythrocyte sedimentation rate (ESR) (Table 1).
The STA was found to be positive at a dilution of 1:160. Blood
cultures were negative. An ECG showed sinus tachycardia, and
chest radiography was normal. TTE showed normal valves but
marked pericardial effusion of 13 mm in thickness. There were no
signs of cardiac tamponade. Pericardial effusion was also observed
on thoracic computed tomography (CT) (Figure 1A). In accordance
with these ﬁndings, a diagnosis of Brucella-related pericarditis was
made and our patient was treated with oral doxycycline 100 mg
twice daily for 2 months plus intramuscular streptomycin 1 g once
daily for the ﬁrst 3 weeks. His symptoms regressed rapidly 4 daysFigure 1. (A) Pericardial effusion in thoracic CT (arrows). (after the initiation of treatment. TTE and thoracic CT were normal 1
month after the beginning of treatment (Figure 1B), and he showed
no signs of relapse during 7 months of follow-up.
2.3. Case 3
A 51-year-old female patient was admitted to the cardiology
outpatient clinic with fever, chest pain, dyspnea, palpitations, and
fatigue persisting for a month. She also had a history of generalized
arthralgia, headache, and night sweats, was working as a stock
farmer, and had been drinking raw cow milk. On physical
examination, the only abnormalities were a systolic murmur
(grade 3/6) and hepatosplenomegaly. Laboratory investigations
revealed anemia, leukocytosis, elevated CRP level, and high ESR,
with elevated serum urea and creatinine levels (Table 1). The STA
was positive at a dilution of 1:320, and Brucella melitensis was
isolated from two blood cultures. An ECG was normal, but chest
radiography revealed cardiomegaly. TTE and thoracic CT showed
pericardial effusion, without any signs of cardiac tamponade
(Figure 2). Oral doxycycline 100 mg twice daily plus oral rifampin
600 mg once daily were started. Her symptoms regressed rapidly 6
days after the initiation of treatment, and the patient was
discharged. The patient was then lost to follow-up.
2.4. Case 4
A 51-year-old female patient was admitted to our clinic due to
fever, dyspnea, fatigue, generalized arthralgia, and chest pain of 3-
week duration. She was living in a rural region and drinking raw
cow milk. A physical examination was normal other thanB) Thoracic CT is normal after 1 month of treatment.
Figure 2. Thoracic CT showing pericardial effusion (arrows).
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CRP, and a high ESR (Table 1). An ECG showed sinus tachycardia.
The STA was positive at a dilution of 1:320. Blood cultures were
sterile. TTE suggested minimal pericardial effusion, and there were
no signs of cardiac tamponade. Oral doxycycline 100 mg twice
daily plus intramuscular streptomycin 1 g once daily were started.
Her symptoms regressed 4 days after the initiation of treatment.
Streptomycin was stopped due to raised serum urea and creatinine
levels after 10 days of treatment, and oral rifampin 900 mg once
daily was added. Doxycycline and rifampin were maintained for 2
months. A TTE was normal at the end of treatment. She showed no
signs of relapse after 6 months of follow-up.
3. Discussion
Brucellosis is a signiﬁcant health problem in Turkey.6 The
disease is a systemic infection and the clinical presentation varies
widely from asymptomatic and mild to severe disease. Infected
animals and their products, particularly unpasteurized milk and
dairy products, are common sources of infecion.1 Our patients had
a history of eating fresh cheese or drinking raw cow milk.
The spleen, liver, and bone marrow are the most frequently
involved sites. Cardiovascular, gastrointestinal, osteoarticular,
urogenital, hematological, and neurological complications may
arise.7 Cardiovascular complications (endocarditis, pericarditis,
and myocarditis) are extremely rare.5 Brucellar endocarditis is the
most common cardiovascular involvement of the disease and
usually involves the aortic valve and less frequently the mitral
valve. The covers damaged due to rheumatic fever, congenital
malformations, or scleroderma are more likely to be affected.1 It
has a subclinical course and poor prognosis without any surgical
treatment.8 Replacement of the affected valve is necessary after 5–
7 days of antibiotic therapy.9 In the study of Tas¸ ova et al.,10
endocarditis was found in only one of 238 cases of brucellosis. In
another a study, Gur et al.11 reported two cases of brucellar
endocarditis in the presence of concomitant myocarditis and
pericarditis in a series of 283 cases with brucellosis. In cases of
endocarditis, myocarditis and pericarditis are frequent, but pure
pericarditis or myocarditis appears to be exceptional as the main
feature of the disease.12,13 Indeed, by searching the MEDLINE
database for published articles using the words ‘pericarditis’ and
‘brucellosis’, we identiﬁed only 13 reports in the literature of adult
patients with brucellosis, including 16 patients with brucellosis-
related pericarditis in the absence of concomitant endocardi-
tis,5,12,14–24 of which 10 had appropriate information for analysis(Table 2). In a study of 530 cases from Spain, only one patient had
isolated brucellar pericarditis.14 A case of pure brucellar pericar-
ditis proven by blood culture has been reported by Gatselis et al.5
Anguita et al.15 reported two cases of B. melitensis pericarditis.
Cuisinier et al.16 reported acute pericarditis in a patient with
relapsed brucellosis. Two reports of pure Brucella pericarditis with
culture of B. melitensis from pericardial effusion have been reported
by Ugartemendı´a et al.17 Karagiannis et al.18 reported a case with
serologically diagnosed brucellosis developing acute pericarditis,
without endocarditis. In this case, pericardiocentesis was required
because of cardiac tamponade.
The cause of cardiac damage in brucellosis is uncertain. It may
be due to a direct effect of the microorganism, as suggested by
pericardial ﬂuid cultures or by local deposits of immunocomplexes
seen in cardiac biopsies.5 Chest pain, dyspnea, and fever are
common in pericarditis. There is pericardial friction rub in half of
the cases.19 The diagnosis is based on the demographic and
epidemiologic characteristics of the disease, the presence of
symptoms, results of serological tests, and isolation of the
microorganism by blood, bone marrow, or pericardial ﬂuid
culture.5 In our series, fever and dyspnea were the common
symptoms in all patients. Echocardiograms showed pericardial
effusion without any additional endocardial abnormalities, and
none of the cases had cardiac tamponade. Surgical intervention
(i.e., pericardiocentesis) and pericardial ﬂuid culture were
performed in only three patients among the total number of 16
cases found in the literature with brucellar pericarditis. Two of
these patients presented with cardiac tamponade, and pericardio-
centesis was performed as a therapeutic approach.17,18 In the rest
of the cases, the diagnosis was made by means of serology, blood
culture, ECG, TTE, and radiology, as well as from the clinical picture.
Diagnosis was based on TTE, radiology, and a positive serology in
three of our patients, and in the other, positive serology with the
isolation of B. melitensis from blood in addition to TTE and
radiology. We conclude that pericardiocentesis, which is per-
formed in order to carry out pericardial ﬂuid analysis (culture), is
not essential in cases with brucellar pericarditis in the absence of
cardiac tamponade.
Forty-ﬁve days of combined antibiotic treatment is sufﬁcient
in cases of pericarditis due to Brucella. Trimethoprim–sulfameth-
oxazole may be added to rifampin–doxycycline therapy in
patients with serous membrane involvement.19 Three of our
patients received combined antibiotic therapy for 2 months
(rifampin–doxycycline or doxycycline–streptomycin). We ad-
ministered rifampin and doxycycline to the other patient for 6
days, and her signs and symptoms regressed, but she was then lost
to follow-up.
Brucella endocarditis is a clinical picture with a high mortality,
and this situation can be fatal even if antibiotic treatment is started
immediately, with the addition of surgical interventions.1 When
we searched the literature, the survival rate is high in patients with
brucellosis accompanied by ‘pure pericarditis’. Indeed, only one of
the 16 described patients died, and that patient had cardiac
tamponade and also hepatic cirrhosis.17 In our series, three
patients completed antibiotic treatment, and were doing well after
follow-up durations of 6–9 months. They were completely
asymptomatic and without any pathological echocardiogram
ﬁndings.
Corticosteroids can be used in neurobrucellosis, but there is no
consensus on the use of steroids in brucellar pericarditis.3 In the
literature, there are only four cases with brucellar pericarditis who
received anti-inﬂammatory treatment (prednisone in two cases,
indomethacin in one, and acetylsalicylic acid in one patient) in
addition to antibiotics (Table 2).17,18,20,21 The other cases (n = 7)
did not receive any anti-inﬂammatory medications, and six of
them recovered fully with antibiotics alone. We also did not
Table 2
Adult patients with brucellar pericarditis published in the literature
Author,
year (Ref.)
Cases, n Age,
years/sex
Clinical
presentation
ECG ﬁndings TTE ﬁndings Serum
agglutination
Blood
cultures
Pericardial
ﬂuid cultures
Antibiotic treatment
(duration, weeks)
Anti- inﬂammatory
treatment
(duration, weeks)
Follow-up
time,
months
Outcome
Ugartemendı´a
et al., 1985 (17)
2 48/F Fever, chest pain NA PE 1/320 B. melitensis B. melitensis Co-trimoxazole, streptomycin,
oxytetracycline (3)
Prednisone (6) 18 Cure
52/M Fever, chest pain NA PE, calciﬁc
aortic
stenosis
1/640 B. melitensis B. melitensis Co-trimoxazole, streptomycin,
oxytetracycline, rifampin (3)
None 18 Death
Gomez-Huelgas
et al., 1986 (12)
1 29/M Fever, retrosternal
pain
Sinus tachycardia,
low QRS
complexes
PE Negative B. melitensis NA Doxycycline (4),
streptomycin (2)
None NA Cure
Rivera
et al., 1988 (22)
1 55/M Fever, chest pain NA PE 1/640 B. melitensis NA Rifampin, doxycycline (NA) None NA Cure
Martinez
et al., 2002 (21)
1 17/M Retrosternal pain ST elevation,
T negativity
Pericardial
thickening
1/640 B. melitensis NA Doxycycline, rifampin,
co-trimoxazole (8)
Acetylsalicylic
acid
12 Cure
Karagiannis
et al., 2003 (18)
1 55/M Fever, dyspnea Atrial ﬁbrillation PE 1/1280 Negative Negative Doxycycline (6),
streptomycin (2)
Indomethacin (2) 6 Cure
Hatipog˘lu
et al., 2004 (23)
2 62/F Fever, dyspnea,
chest pain
NA PE 1/640 Negative NA Doxycycline, ciproﬂoxacin (6),
gentamicin (2)
None NA Cure
64/F Dyspnea, hip pain NA PE 1/320 B. melitensis NA Doxycycline, rifampin,
oﬂoxacin (24)
None 6 Cure
Demirdag˘
et al., 2005 (19)
1 50/F Fever, dyspnea,
chest pain
Sinus
tachycardia
Left ventricular
hypertrophy, PE
1/160 B. melitensis NA Rifampin, doxycycline (6) None NA Cure
Gatselis
et al., 2011 (5)
1 34/M Fever, arthralgia Sinus rhythm PE 1/2560 Brucella spp NA Doxycycline, rifampin (12),
streptomycin (3)
None 12 Cure
Our series 4 79/F Fever, dyspnea,
arthralgia
Sinus rhythm Left ventricular
hypertrophy, PE
1/320 Negative NA Rifampin, doxycycline (8) None 9 Cure
33/M Fever, dyspnea,
palpitation
Sinus rhythm PE 1/160 Negative NA Doxycycline (8),
streptomycin (3)
None 7 Cure
51/F Fever, dyspnea,
chest pain
Sinus rhythm PE 1/320 B. melitensis NA Rifampin, doxycycline None NA NA
51/F Fever, dyspnea,
chest pain
Sinus tachycardia PE 1/320 Negative NA Rifampin, doxycycline (8) None 6 Cure
ECG, electrocardiography; F, female; M, male; NA, not available; PE, pericardial effusion; TTE, transthoracic echocardiography.
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cure was achieved and maintained in three of the cases (Table 2).
Since the prevalence of pericarditis in brucellosis is low, in order
to test this in our patient cohort, we also tried to investigate the
frequency of clinically silent pericardial effusion among patients
with brucellosis. We performed routine TTE in 72 consecutive
patients with newly diagnosed brucellosis in the absence of any
signs and symptoms of pericarditis over a period of 6 months
(between March and September 2012). None of these patients had
pericardial effusion, so after this ﬁnding, we can say that TTE is a
necessary diagnostic procedure only in patients with brucellosis
who have signs and symptoms of pericarditis.
In conclusion, brucellar pericarditis is a rare clinical entity, and
the morbidity and mortality in patients with brucellar pericarditis is
low, in contrast to cases presenting with endocarditis. Sampling the
pericardial ﬂuid for culture is not necessary in order to make the
diagnosis of brucellar pericarditis, and pericardiocentesis should
only be performed in patients with cardiac tamponade. Moreover,
the choice of antibiotics and the duration of treatment do not differ
between brucellosis cases with and without isolated pericarditis.
Adding anti-inﬂammatory drugs to the therapy may be beneﬁcial in
selected cases with brucellar pericarditis, but this treatment
modality is most probably not essential. A prospective controlled
randomized trial is necessary to answer this question. Although the
prevalence of pericarditis in brucellosis is low, brucellar pericarditis
should always be kept in mind in patients with acute or chronic
pericarditis, especially in areas where brucellosis is endemic.
Conﬂict of interest: No conﬂict of interest to declare.
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